Incident Type II Diabetes Mellitus Among Patients Exposed to the Combination of Pravastatin and Paroxetine

Registration

Registration

NCT01602913

Study type

OBSERVATIONAL

Status

COMPLETED

Enrollment

1

Start

2011-12

Primary completion

2012-05

Lead sponsor

GlaxoSmithKline

Conditions

Depression, Postpartum

Interventions

DRUG:Pravastatin alone; DRUG:Paroxetine alone; DRUG:Pravastatin and paroxetine combined

Results posted

FALSE

Secondary identifiers

OTHER:WEUSKOP5966

Registered primary outcomes

• Incidence of T2DM defined as having at least 2 diagnostic codes indicating T2DM after the index date, or 1 diagnostic code and 1 prescription of oral anti-diabetic medications or insulin (or Byetta and Victoza) after the index date [Up to ten years]